|Bid||38.20 x 900|
|Ask||0.00 x 800|
|Day's Range||39.01 - 40.16|
|52 Week Range||20.89 - 42.64|
|Beta (3Y Monthly)||1.86|
|PE Ratio (TTM)||806.94|
|Earnings Date||Apr 30, 2019 - May 6, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||44.00|
Cardiovascular Systems (CSII) hopes that new product menu will deliver minimum 10% growth in its core business during the second half of fiscal 2019.
Scott Ward became the CEO of Cardiovascular Systems, Inc. (NASDAQ:CSII) in 2016. First, this article will compare CEO compensation with compensation at similar sized companies. Next, we'll consider growth thatRead More...
Cardiovascular Systems, Inc. , a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral
NEW YORK , March 1, 2019 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600: Washington Real Estate Investment Trust (NYSE: WRE) will replace Investment Technology ...
Wright Medical's (WMGI) top-line growth in fourth-quarter 2018 can be attributed to solid performance by the Upper and the Lower Extremities segments.
With regard to its 2019 PBM selling season, CVS Health (CVS) notes that the net benefits from this selling season are expected to be modest on Anthem-related headwinds.
DaVita (DVA) steadily expands in international markets. Moreover, the company has witnessed Dialysis services in the United States lately.
On Wednesday, February 27, 2019, Cardiovascular Systems’ Chairman, President and Chief Executive Officer, Scott Ward, and Chief Operating Officer, Rhonda Robb, will present at the 8th Annual SVB Leerink Global Healthcare Conference at 3:00 p.m.
Surmodics' (SRDX) solid efforts to improve its research and development stature are likely to prove beneficial in the quarters ahead.
NEW YORK, Feb. 19, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Cardiovascular Systems (CSII) has been firing on all cylinders of late to expand its geographical presence. The company is progressing well with its objective to introduce OAS globally.
A growing orthopedic market and strong international expansion make Wright Medical (WMGI) a promising investment pick at the moment.
Intuitive Surgical's (ISRG) solid exposure to robotics & medical mechatronics is commendable. Its robot-based da Vinci Surgical System for minimally-invasive surgery is an added positive.
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of 125.00% and 0.92%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?